Surgery Partners EPS - Earnings per Share 2013-2024 | SGRY
Surgery Partners eps - earnings per share from 2013 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Surgery Partners Annual EPS | |
|---|---|
| 2023 | $-0.09 |
| 2022 | $-0.59 |
| 2021 | $-1.12 |
| 2020 | $-3.19 |
| 2019 | $-2.29 |
| 2018 | $-4.96 |
| 2017 | $-1.64 |
| 2016 | $0.20 |
| 2015 | $0.04 |
| 2014 | $-2.04 |
| 2013 | $-0.28 |
| 2012 | $1.92 |
| Surgery Partners Quarterly EPS | |
|---|---|
| 2024-03-31 | $-0.10 |
| 2023-12-31 | $0.00 |
| 2023-09-30 | $-0.04 |
| 2023-06-30 | $0.15 |
| 2023-03-31 | $-0.20 |
| 2022-12-31 | $-0.24 |
| 2022-09-30 | $-0.28 |
| 2022-06-30 | $-0.21 |
| 2022-03-31 | $0.14 |
| 2021-12-31 | $0.12 |
| 2021-09-30 | $-0.28 |
| 2021-06-30 | $-0.39 |
| 2021-03-31 | $-0.57 |
| 2020-12-31 | $-0.11 |
| 2020-09-30 | $-1.46 |
| 2020-06-30 | $-0.86 |
| 2020-03-31 | $-0.76 |
| 2019-12-31 | $-0.59 |
| 2019-09-30 | $-0.51 |
| 2019-06-30 | $-0.59 |
| 2019-03-31 | $-0.60 |
| 2018-12-31 | $-3.25 |
| 2018-09-30 | $-0.61 |
| 2018-06-30 | $-0.57 |
| 2018-03-31 | $-0.53 |
| 2017-12-31 | $-0.83 |
| 2017-09-30 | $-0.66 |
| 2017-06-30 | $-0.09 |
| 2017-03-31 | $-0.06 |
| 2016-12-31 | $0.36 |
| 2016-09-30 | $-0.05 |
| 2016-06-30 | $0.04 |
| 2016-03-31 | $-0.15 |
| 2015-12-31 | $0.52 |
| 2015-09-30 | $-0.10 |
| 2015-06-30 | $-0.17 |
| 2015-03-31 | $-0.21 |
| 2014-12-31 | $0.00 |
| 2014-09-30 | $-0.22 |
| 2013-12-31 | $0.00 |
| 2012-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.017B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.903B | 15.80 |
| Cencora (COR) | United States | $47.741B | 18.61 |
| ICON (ICLR) | Ireland | $26.139B | 24.68 |
| DiDi Global (DIDIY) | China | $21.386B | 0.00 |
| Avantor (AVTR) | United States | $15.283B | 22.50 |
| CochLear (CHEOY) | Australia | $14.173B | 0.00 |
| Revvity (RVTY) | United States | $13.191B | 23.14 |
| Natera (NTRA) | United States | $13.190B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.644B | 41.60 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| Charles River Laboratories (CRL) | United States | $10.809B | 20.69 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.137B | 0.00 |
| Solventum (SOLV) | United States | $8.860B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.681B | 0.00 |
| HealthEquity (HQY) | United States | $7.198B | 46.21 |
| Organon (OGN) | United States | $5.431B | 5.15 |
| Bausch + Lomb (BLCO) | Canada | $5.256B | 21.04 |
| Doximity (DOCS) | United States | $5.107B | 35.77 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.623B | 37.96 |
| Sotera Health (SHC) | United States | $3.369B | 16.53 |
| GoodRx Holdings (GDRX) | United States | $2.859B | 108.86 |
| Agilon Health (AGL) | United States | $2.677B | 0.00 |
| Progyny (PGNY) | United States | $2.487B | 42.82 |
| AMN Healthcare Services Inc (AMN) | United States | $2.029B | 8.04 |
| NovoCure (NVCR) | Jersey | $2.014B | 0.00 |
| Premier (PINC) | United States | $1.949B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.852B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.757B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| CareDx (CDNA) | United States | $0.749B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.695B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.680B | 7.21 |
| Auna S.A (AUNA) | Luxembourg | $0.568B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
| Enhabit (EHAB) | United States | $0.426B | 42.50 |
| ModivCare (MODV) | United States | $0.367B | 6.87 |
| Sonida Senior Living (SNDA) | United States | $0.345B | 0.00 |
| DocGo (DCGO) | United States | $0.310B | 16.94 |
| LifeMD (LFMD) | United States | $0.288B | 0.00 |
| MultiPlan (MPLN) | United States | $0.238B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.49 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| Co-Diagnostics (CODX) | United States | $0.043B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.035B | 0.00 |
| Oncology Institute (TOI) | United States | $0.031B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.018B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |